Non–Small Cell Lung Cancer Coverage from Every Angle

Ramaswamy Govindan, MD, and Jaafar Bennouna, MD: Results From the AvaALL Trial

Posted: Monday, June 5, 2017

Ramaswamy Govindan, MD, of Washington University, and Jaafar Bennouna, MD, of the University of Nantes Institut de Cancerologie de l’Ouest, discuss efficacy and safety results in a phase III study of standard of care with or without continuous bevacizumab treatment beyond progression in patients with advanced non–small cell lung cancer progressing after first-line bevacizumab and chemotherapy.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.